|
|
Remarkably, mankind has developed a range of vaccines in little more than 12 months since the identification of the novel coronavirus in late 2019. The big issue as we enter 2021 is how should those vaccines most responsibly be rolled out? Stuart McDonald, Yifei Gong and John Roberts, three actuaries working on demographic and epidemiological data, have been to the fore of analysis of the benefits of the strategic distribution of early vaccines to the most vulnerable categories of the population. We set out here a summary of their recent work.
Disclaimer:
This article does not necessarily represent the opinion of the AAE.
This article was published in The European Actuary No. 25 – March 2021
